Split history for Bio-Rad Laboratories Inc. - Ordinary Shares - Class B
Bio-Rad Laboratories Inc. - Ordinary Shares - Class B has split the face value 9 times since Aug. 26, 1976. Bio-Rad Laboratories Inc. - Ordinary Shares - Class B had last split the face value of its shares from $2 to $1 in 2002.The share has been quoting on an ex-split basis from March 8, 2002.
| Split Date | Split Ratio |
|---|---|
| 08 Mar 2002 | 2:1 Stock split |
| 03 Jun 1996 | 3:2 Stock split |
| 11 Jun 1986 | 3:2 Stock split |
| 01 Aug 1985 | 3:2 Stock split |
| 19 Mar 1980 | 2:1 Stock split |
| 26 Oct 1979 | 5:4 Stock split |
| 09 Nov 1978 | 5:4 Stock split |
| 26 Jul 1977 | 5:4 Stock split |
| 26 Aug 1976 | 5:4 Stock split |
Bio-Rad Laboratories Inc. - Ordinary Shares - Class B Dividend history
Bio-Rad Laboratories Inc. - Ordinary Shares - Class B has not given any dividends since Jan 1, 2000.
See all forthcoming dividendsBoard Meetings - Bio-Rad Laboratories Inc. - Ordinary Shares - Class B
The next board meeting for Bio-Rad Laboratories Inc. - Ordinary Shares - Class B is on 04 Sep 2025 for the purpose of 2025 Wells Fargo Healthcare Conference
| Ex-Date | Purpose | Notes |
|---|---|---|
| 30 Oct 2025 | Bio-Rad Laboratories Inc Third Quarter Earnings Results for 2025 | - |
| 30 Oct 2025 | Bio-Rad Laboratories Inc Third Quarter Earnings Conference Call for 2025 | - |
| 04 Sep 2025 | 2025 Wells Fargo Healthcare Conference | - |
| 01 Aug 2025 | Bio-Rad Laboratories Inc Second Quarter Earnings Conference Call for 2025 | - |
| 01 Aug 2025 | Bio-Rad Laboratories Inc Second Quarter Earnings Results for 2025 | - |
| 31 Jul 2025 | Bio-Rad Laboratories Inc Second Quarter Earnings Results for 2025 | - |
| 31 Jul 2025 | Bio-Rad Laboratories Inc Second Quarter Earnings Conference Call for 2025 | - |
| 21 May 2025 | 2025 RBC Capital Markets Global Healthcare Conference | - |
| 07 May 2025 | Bio-Rad Laboratories Inc First Quarter Earnings Conference Call for 2025 | - |
| 07 May 2025 | Bio-Rad Laboratories Inc First Quarter Earnings Results for 2025 | - |